Education
About Us
Working with TipRanks
Follow Us
Novavax (NVAX)
NASDAQ:NVAX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.12B | $ 682.16M | $ 556.38M | $ 1.60B | $ 197.58M |
| Gross Profit | $ 1.05B | $ 479.42M | $ 212.61M | $ 696.31M | $ 197.58M |
| Operating Income | $ 563.27M | $ -248.93M | $ -566.51M | $ -644.74M | $ -1.69B |
| EBITDA | $ 590.88M | $ -108.04M | $ -487.39M | $ -604.71M | $ -1.68B |
| Net Income | $ 440.30M | $ -187.50M | $ -545.06M | $ -657.94M | $ -1.74B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 735.08M | $ 923.12M | $ 568.50M | $ 1.34B | $ 1.52B |
| Total Assets | $ 1.18B | $ 1.56B | $ 1.80B | $ 2.26B | $ 2.58B |
| Total Debt | $ 248.81M | $ 230.42M | $ 229.08M | $ 549.78M | $ 453.99M |
| Net Debt | $ 8.18M | $ -299.81M | $ -339.42M | $ -787.10M | $ -1.06B |
| Total Liabilities | $ 1.30B | $ 2.18B | $ 2.51B | $ 2.89B | $ 2.93B |
| Stockholders' Equity | $ -127.75M | $ -623.84M | $ -716.93M | $ -634.08M | $ -351.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -250.19M | $ -100.32M | $ -772.77M | $ -508.92M | $ 265.46M |
| Operating Cash Flow | $ -244.63M | $ -87.26M | $ -713.97M | $ -415.94M | $ 322.95M |
| Investing Cash Flow | $ -78.27M | $ -204.04M | $ -58.81M | $ -92.98M | $ 100.15M |
| Financing Cash Flow | $ 27.74M | $ 260.58M | $ 4.47M | $ 324.99M | $ 461.71M |